Sridhar Vemula

Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

Mohammad Ali, Deok-Ryun Kim, M. S. Dhingra, 2019, PloS one.

Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

Jerome H. Kim, T. Wartel, G. Rai, 2021, Human vaccines & immunotherapeutics.

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

S. Uranw, T. Wartel, Deok-Ryun Kim, 2021, The Lancet. Infectious diseases.

Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.

Jerome H. Kim, J. Yang, T. Wartel, 2022, Vaccine.

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal

S. Uranw, B. Khanal, A. Ghimire, 2023, Human Vaccines & Immunotherapeutics.